In this issue:
PRECIS: efficacy and safety of ASCT vs cranial radiotherapy for PCNSL
CAR T cell therapy vs ASCT for patients with double and triple-hit RR lymphoma
Explicating the role of allogeneic transplant for Ph+ ALL in first remission
Substantial late effect burden in lymphoma survivors after ASCT
Risk of SMN after TBI conditioned alloSCT in paediatric ALL
Do lenalidomide-combination maintenance regimens improve survival in high-risk MM?
Dysgeusia is common after ASCT and impacts nutrition
ASCT deepens responses in MM in era of novel agent induction therapy
Please login below to download this issue (PDF)